Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001455659 | SCV001659424 | likely benign | Brugada syndrome 8 | 2024-04-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004616734 | SCV005128584 | likely benign | Cardiovascular phenotype | 2024-04-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV001701166 | SCV001918159 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001701166 | SCV001970301 | benign | not specified | no assertion criteria provided | clinical testing |